$14.85
0.392.70%
At close: -
$14.85
0.000.00%
After Hours: May 2, 4:01 PM EDT
Comments
Loading...
Anika Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ANIK | Benzinga
Anika Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$0.090
Quarterly Revenue Estimate
$27.50M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$119.91M
Analyze the earnings history of Anika Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIK | Anika Therapeutics | $0.09 | $0.09 | — | — | $40.52M | $27.50M | — | — | 05/09/2025 | Get Alert |
| ANIK | Anika Therapeutics | $0.07 | $0.09 | -$0.03 | -133.33% | $42.97M | $29.00M | $30.60M | 5.52% | 03/12/2025 | Get Alert |
| ANIK | Anika Therapeutics | $0.00 | -$0.01 | -$0.25 | -2400.00% | $41.47M | $42.08M | $38.75M | -7.91% | 10/31/2024 | Get Alert |
| ANIK | Anika Therapeutics | $0.06 | $0.05 | $0.17 | 240.00% | $44.30M | $42.10M | $41.92M | -0.43% | 08/08/2024 | Get Alert |
| ANIK | Anika Therapeutics | -$0.36 | -$0.19 | $0.09 | 147.37% | $37.92M | $39.14M | $40.52M | 3.53% | 05/08/2024 | Get Alert |
| ANIK | Anika Therapeutics | -$0.21 | -$0.26 | $0.05 | 119.23% | $39.62M | $41.40M | $42.97M | 3.79% | 03/13/2024 | Get Alert |
| ANIK | Anika Therapeutics | -$0.05 | -$0.37 | $0.00 | 100.00% | $40.26M | $38.27M | $41.47M | 8.35% | 11/02/2023 | Get Alert |
| ANIK | Anika Therapeutics | -$0.12 | -$0.27 | $0.06 | 122.22% | $39.66M | $40.56M | $44.30M | 9.23% | 08/08/2023 | Get Alert |
| ANIK | Anika Therapeutics | -$0.11 | -$0.30 | -$0.36 | -20.00% | $36.69M | $37.28M | $37.92M | 1.73% | 05/09/2023 | Get Alert |
| ANIK | Anika Therapeutics | -$0.23 | -$0.24 | -$0.21 | 12.50% | $35.82M | $37.70M | $39.62M | 5.10% | 03/06/2023 | Get Alert |
| ANIK | Anika Therapeutics | $0.05 | -$0.25 | -$0.05 | 80.00% | $39.54M | $37.59M | $40.26M | 7.11% | 11/08/2022 | Get Alert |
| ANIK | Anika Therapeutics | $0.09 | -$0.23 | -$0.12 | 47.83% | $38.15M | $37.85M | $39.66M | 4.77% | 08/03/2022 | Get Alert |
| ANIK | Anika Therapeutics | $0.06 | -$0.36 | -$0.11 | 69.44% | $34.29M | $32.90M | $36.69M | 11.53% | 05/05/2022 | Get Alert |
| ANIK | Anika Therapeutics | $0.12 | -$0.25 | -$0.23 | 8.00% | $32.69M | $32.05M | $35.82M | 11.77% | 03/08/2022 | Get Alert |
| ANIK | Anika Therapeutics | $0.05 | -$0.21 | $0.05 | 123.81% | $31.69M | $36.32M | $39.54M | 8.85% | 11/04/2021 | Get Alert |
| ANIK | Anika Therapeutics | $0.09 | -$0.06 | $0.09 | 250.00% | $30.68M | $34.76M | $38.15M | 9.74% | 08/05/2021 | Get Alert |
| ANIK | Anika Therapeutics | $0.45 | -$0.12 | $0.06 | 150.00% | $35.40M | $32.20M | $34.29M | 6.50% | 05/06/2021 | Get Alert |
| ANIK | Anika Therapeutics | $0.43 | -$0.01 | $0.12 | 1300.00% | $29.77M | $33.50M | $32.69M | -2.42% | 03/04/2021 | Get Alert |
| ANIK | Anika Therapeutics | $0.64 | -$0.01 | $0.05 | 600.00% | $29.70M | $30.11M | $31.69M | 5.26% | 11/04/2020 | Get Alert |
| ANIK | Anika Therapeutics | $0.67 | -$0.24 | $0.09 | 137.50% | $30.42M | $20.37M | $30.68M | 50.60% | 07/30/2020 | Get Alert |
| ANIK | Anika Therapeutics | $0.31 | — | $0.45 | — | $24.72M | $31.53M | $35.40M | 12.26% | 05/07/2020 | Get Alert |
Anika Therapeutics (ANIK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-12 | $-0.03 | $0.09 | -133.3 % |
| Q3 | 2024-10-31 | $-0.25 | $-0.01 | -2400.0 % |
| Q2 | 2024-08-08 | $0.17 | $0.05 | 240.0 % |
| Q1 | 2024-05-08 | $0.09 | $-0.19 | 147.4 % |
Anika Therapeutics (ANIK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-12 | $30.60M | $29.00M | 5.52 % |
| Q3 | 2024-10-31 | $38.75M | $42.08M | -7.91 % |
| Q2 | 2024-08-08 | $41.92M | $42.10M | -0.43 % |
| Q1 | 2024-05-08 | $40.52M | $39.14M | 3.53 % |
FAQ
When is Anika Therapeutics (NASDAQ:ANIK) reporting earnings?
Anika Therapeutics (ANIK) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on March 12, 2025 for Q4.
What were the latest earnings per share (EPS) for Anika Therapeutics (NASDAQ:ANIK)?
The Actual EPS was $-0.03, which missed the estimate of $0.09.
What were Anika Therapeutics’s (NASDAQ:ANIK) revenues?
The Actual Revenue was $30.6M, which beat the estimate of $29M.
Browse earnings estimates, EPS, and revenue on all stocks.
